Jaguar Health (JAGX) Assets Growth (3y) (2017 - 2026)
Jaguar Health (JAGX) Assets Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.04% |
| Dec 31, 2025 | -56.15% |
| Sep 30, 2025 | -1.19% |
| Jun 30, 2025 | -1.09% |
| Mar 31, 2025 | -0.92% |
| Dec 31, 2024 | 0.10% |
| Sep 30, 2024 | -0.45% |
| Jun 30, 2024 | -4.03% |
| Mar 31, 2024 | -6.93% |
| Dec 31, 2023 | 5.82% |
| Sep 30, 2023 | 7.79% |
| Jun 30, 2023 | 11.56% |
| Mar 31, 2023 | 19.60% |
| Dec 31, 2022 | 9.23% |
| Sep 30, 2022 | 12.91% |
| Jun 30, 2022 | 11.42% |
| Mar 31, 2022 | 9.17% |
| Dec 31, 2021 | 9.08% |
| Sep 30, 2021 | 8.71% |
| Jun 30, 2021 | 14.64% |